Encéphalopathie radique sous immunothérapie. Surveillez les symptômes neurologiques
M. Godeau, Nicolás Meyer(Hôpitaux Universitaires de Strasbourg), M. Mourguet, Antônio Augusto Dall’Agnol Modesto, P. Nicol, J. Ofaiche, S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), S. Boulinguez(Institut universitaire du cancer de Toulouse Oncopole), V. Sibaud(Institut Claudius Regaud), Damien Biotti
Cited by 0
Related Papers
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
|The Lancet Oncology|2017|780
Diagnosis and classification of optic neuritis
|The Lancet Neurology|2022|290
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
|European Journal of Cancer|2017|284